Jylamvo

List of products in the National Drug Code with proprietary name jylamvo. Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis that has not responded to other treatments. It may also be used to control juvenile rheumatoid arthritis. Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and suppressing the immune system. Early treatment of rheumatoid arthritis with more aggressive therapy such as methotrexate helps to reduce further joint damage and to preserve joint function.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
81927-204Jylamvo MethotrexateSolutionOralShorla Oncology Inc.Human Prescription Drug